6th World (CNS) summit - Targeting Neurodegeneration Diseases
In-Person Event
Feb 20 - 22, 2018
Boston, Massachusetts, USA
OVERVIEW
6th Annual World Central nervous system (CNS) summit - Targeting Neurodegeneration Diseases is organized by Hanson Wade and will be held during Feb 20 - 22, 2018 at The Westin Copley Place, Boston, Massachusetts, United States of America.
The last 12 months have seen the neurodegenerative community make numerous strides into understanding these disorders. However, 2017 has been a rocky journey, particularly so for Alzheimer’s Disease, adding weight to the growing concern as to whether there is a fundamental flaw in our understanding of the disease, its mechanisms or our path to targeting it.
As Program Director & Researcher for the 6th Annual World CNS Summit, I invite you to join a truly diverse group of professionals from biopharmaceutical, technology and academic institutions, in paving the path forward for neurodegenerative therapeutics.
This year we have refined the theme of the meeting to ‘transforming discovery and translational research into disease modifying therapeutics’ to exemplify the vast opportunities that remain at our fingertips.
Focused specifically on the translational barriers in neurodegenerative R&D, this is an opportunity to look beyond A-Beta Tauthe and other classical targets of neurodegeneration. It will highlight foundational research into promising targets, such as neuroinflammation, and the strategic approaches to modulate these.
Join over 60 biopharmaceutical organizations and 100 experts in harnessing new innovations, to tackle the challenges at the crux of your pipeline. Redefine the use of preclinical models of neurodegeneration, enhance their application in your translational research and advance translational biomarker discovery - from target engagement to disease progression.
Additional details will be posted as soon as they are available.
The last 12 months have seen the neurodegenerative community make numerous strides into understanding these disorders. However, 2017 has been a rocky journey, particularly so for Alzheimer’s Disease, adding weight to the growing concern as to whether there is a fundamental flaw in our understanding of the disease, its mechanisms or our path to targeting it.
As Program Director & Researcher for the 6th Annual World CNS Summit, I invite you to join a truly diverse group of professionals from biopharmaceutical, technology and academic institutions, in paving the path forward for neurodegenerative therapeutics.
This year we have refined the theme of the meeting to ‘transforming discovery and translational research into disease modifying therapeutics’ to exemplify the vast opportunities that remain at our fingertips.
Focused specifically on the translational barriers in neurodegenerative R&D, this is an opportunity to look beyond A-Beta Tauthe and other classical targets of neurodegeneration. It will highlight foundational research into promising targets, such as neuroinflammation, and the strategic approaches to modulate these.
Join over 60 biopharmaceutical organizations and 100 experts in harnessing new innovations, to tackle the challenges at the crux of your pipeline. Redefine the use of preclinical models of neurodegeneration, enhance their application in your translational research and advance translational biomarker discovery - from target engagement to disease progression.
Additional details will be posted as soon as they are available.
KEY DATES
20 Feb, 2018
Event Start Date
22 Feb, 2018
Event End Date
SPECIALITIES
NeurologyPsychiatrySUGGESTED HOTELS
CONFERENCE VENUE
The Westin Copley PlaceRELATED CONFERENCES & LIVE WEBINARS
Quick Links